Sartorius AG

Core Business

Sartorius AG is a leading international pharmaceutical and laboratory equipment supplier providing critical single-use bioprocessing technologies essential for CGT manufacturing. In 2025, Sartorius generated approximately EUR 3.54 billion ($3.8 billion) in revenue with a strong 29.7% EBITDA margin. Its single-use bioreactor systems, filtration technologies, and cell culture consumables have become the industry standard for sterile cell therapy and viral vector production worldwide.

Global Presence

Headquartered in Goettingen, Germany, Sartorius operates approximately 60 manufacturing and sales locations worldwide with 14,000 employees. The company serves customers in over 100 countries, with particular strength in European and North American biotech manufacturing hubs. Its 150-year heritage in laboratory and process technology provides deep institutional knowledge.

Key Strengths

Sartorius' deep expertise in single-use bioprocessing, combined with its century-and-a-half heritage in laboratory technology, creates a trusted brand essential to CGT manufacturing. The company's recurring consumables revenue model, high EBITDA margins, and strategic acquisitions position it as a critical infrastructure provider in the expanding CGT ecosystem. Its market leadership in single-use bioreactors provides a high-moat competitive position.

VerityRank Score

Sartorius AG achieves a VerityRank Score of 90/100, reflecting its market leadership in single-use bioprocessing technologies, strong financial performance, and essential role in the global CGT manufacturing supply chain.